Crossmark

Postauthorization Safety Study (NISSO) Assessing the Long-Term Safety Profile of Sonidegib in Patients With Locally Advanced Basal Cell Carcinoma: Interim Analysis From the Spanish Cohort

Crossref DOI link: https://doi.org/10.1016/j.ad.2025.104524

Published Print: 2026-02

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Beà Ardébol, S.

Pérez-Pastor, G.M.

Fernández-de-Misa, R.

Botella-Estrada, R.

Ruiz-Salas, V.

Flórez, Á.

Mayor Arenal, M.

Fuente González, M.J.

Bassas-Freixas, P.

Toll, A.

Valerón Almazán, P.

Arntz, R.

Malvehy, J.
Funding

Funding for this research was provided by:

Sun Pharma
License Information

Text and Data Mining valid from 2026-02-01

Text and Data Mining valid from 2026-02-01

Version of Record valid from 2025-12-03
More Information

This article is maintained by: Elsevier

Article Title: Postauthorization Safety Study (NISSO) Assessing the Long-Term Safety Profile of Sonidegib in Patients With Locally Advanced Basal Cell Carcinoma: Interim Analysis From the Spanish Cohort

Journal Title: Actas Dermo-Sifiliográficas

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.ad.2025.104524

Content Type: article

Copyright: © 2025 AEDV. Published by Elsevier España, S.L.U.

Document is current

Any future updates will be listed below